KLRK1 and Crohn disease: Moreover, NKG2D+CD4+ T cells have been demonstrated to exhibit cytotoxic features in Crohn’s disease, being capable of killing target C1R cells (a human B-cell lymphoblastoid line that lacks surface HLA A and B antigens) that had been transfected with MICA in vitro14.